| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |